Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adolescents With Moderate-to-severe Atopic Dermatitis”

58 trials

Showing 20 of 58 results

Large-scale testing (Phase 3)Study completedNCT03661138
What this trial is testing

Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 272
Large-scale testing (Phase 3)Study completedNCT05355818
What this trial is testing

Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema

Who this might be right for
Chronic Hand Eczema
LEO Pharma 98
Large-scale testing (Phase 3)Study completedNCT06004050
What this trial is testing

A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults and Adolescents With Moderate to Severe Chronic Hand Eczema

Who this might be right for
Chronic Hand Eczema
LEO Pharma 362
Not applicableNo Longer AvailableNCT04564755
What this trial is testing

Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pfizer
Not applicableActive Not RecruitingNCT05081557
What this trial is testing

Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 873
Large-scale testing (Phase 3)Study completedNCT04417894
What this trial is testing

Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)

Who this might be right for
Moderate to Severe Atopic Hand and Foot Dermatitis
Regeneron Pharmaceuticals 133
Not applicableUnknownNCT03795506
What this trial is testing

TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)

Who this might be right for
Atopic Dermatitis Eczema
Imperial College London 96
Large-scale testing (Phase 3)Study completedNCT05990725
What this trial is testing

Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic DermatitisEczema
Almirall, S.A. 260
Not applicableLooking for participantsNCT07746427
What this trial is testing

Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis

Who this might be right for
Atopic DermatitisEczema
Weill Medical College of Cornell University 40
Large-scale testing (Phase 3)WithdrawnNCT04666675
What this trial is testing

Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in Brazil

Who this might be right for
Atopic Dermatitis (AD)
AbbVie
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06756126
What this trial is testing

A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Akeso 24
Large-scale testing (Phase 3)Study completedNCT06224192
What this trial is testing

A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Amgen 151
Large-scale testing (Phase 3)Study completedNCT03796676
What this trial is testing

JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pfizer 287
Large-scale testing (Phase 3)Study completedNCT05916365
What this trial is testing

Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Almirall, S.A. 174
Large-scale testing (Phase 3)Study completedNCT05372419
What this trial is testing

(LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 90
Testing effectiveness (Phase 2)Study completedNCT03706040
What this trial is testing

Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis
AbbVie 172
Large-scale testing (Phase 3)Ended earlyNCT05882877
What this trial is testing

Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 2,621
Early research (Phase 1)Study completedNCT03826901
What this trial is testing

Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children

Who this might be right for
Atopic Dermatitis
LEO Pharma 46
Large-scale testing (Phase 3)Study completedNCT05704738
What this trial is testing

Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 532
Large-scale testing (Phase 3)Looking for participantsNCT07765888
What this trial is testing

Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

Who this might be right for
Atopic Dermatitis
Pfizer 375
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation